Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin, nails, hair diseases, pigmentation, acne, wrinkles, psoriasis, and others.
Different techniques are used in dermatology such as topical & systemic medications, laser therapy, radio therapy, photodynamic therapy, vitiligo surgery, dermatological surgery, and others.
In 2019, the market size of Dermatological Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dermatological Drugs.
This report studies the global market size of Dermatological Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Dermatological Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bayer
Johnson & Johnson
Pfizer
Novartis
GlaxoSmithKline
AstraZeneca
Galderma
Amgen
AbbVie
Merck
Market Segment by Product Type
Prescription-Based Drugs
Over-the-Counter Drugs
Market Segment by Application
Acne
Skin Infections
Psoriasis
Dermatitis Drugs
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Dermatological Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Dermatological Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Dermatological Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Different techniques are used in dermatology such as topical & systemic medications, laser therapy, radio therapy, photodynamic therapy, vitiligo surgery, dermatological surgery, and others.
In 2019, the market size of Dermatological Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dermatological Drugs.
This report studies the global market size of Dermatological Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Dermatological Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bayer
Johnson & Johnson
Pfizer
Novartis
GlaxoSmithKline
AstraZeneca
Galderma
Amgen
AbbVie
Merck
Market Segment by Product Type
Prescription-Based Drugs
Over-the-Counter Drugs
Market Segment by Application
Acne
Skin Infections
Psoriasis
Dermatitis Drugs
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Dermatological Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Dermatological Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Dermatological Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Dermatological Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Prescription-Based Drugs
1.3.3 Over-the-Counter Drugs
1.4 Market Segment by Application
1.4.1 Global Dermatological Drugs Market Share by Application (2019-2025)
1.4.2 Acne
1.4.3 Skin Infections
1.4.4 Psoriasis
1.4.5 Dermatitis Drugs
1.4.6 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dermatological Drugs Market Size
2.1.1 Global Dermatological Drugs Revenue 2014-2025
2.1.2 Global Dermatological Drugs Sales 2014-2025
2.2 Dermatological Drugs Growth Rate by Regions
2.2.1 Global Dermatological Drugs Sales by Regions 2014-2019
2.2.2 Global Dermatological Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Dermatological Drugs Sales by Manufacturers
3.1.1 Dermatological Drugs Sales by Manufacturers 2014-2019
3.1.2 Dermatological Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Dermatological Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Dermatological Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Dermatological Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Dermatological Drugs Price by Manufacturers
3.4 Key Manufacturers Dermatological Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Dermatological Drugs Market
3.6 Key Manufacturers Dermatological Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Prescription-Based Drugs Sales and Revenue (2014-2019)
4.1.2 Over-the-Counter Drugs Sales and Revenue (2014-2019)
4.2 Global Dermatological Drugs Sales Market Share by Type
4.3 Global Dermatological Drugs Revenue Market Share by Type
4.4 Dermatological Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Dermatological Drugs Sales by Application
6 United States
6.1 United States Dermatological Drugs Breakdown Data by Company
6.2 United States Dermatological Drugs Breakdown Data by Type
6.3 United States Dermatological Drugs Breakdown Data by Application
7 European Union
7.1 European Union Dermatological Drugs Breakdown Data by Company
7.2 European Union Dermatological Drugs Breakdown Data by Type
7.3 European Union Dermatological Drugs Breakdown Data by Application
8 China
8.1 China Dermatological Drugs Breakdown Data by Company
8.2 China Dermatological Drugs Breakdown Data by Type
8.3 China Dermatological Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Dermatological Drugs Breakdown Data by Company
9.2 Rest of World Dermatological Drugs Breakdown Data by Type
9.3 Rest of World Dermatological Drugs Breakdown Data by Application
9.4 Rest of World Dermatological Drugs Breakdown Data by Countries
9.4.1 Rest of World Dermatological Drugs Sales by Countries
9.4.2 Rest of World Dermatological Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Dermatological Drugs
10.1.4 Dermatological Drugs Product Introduction
10.1.5 Bayer Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Dermatological Drugs
10.2.4 Dermatological Drugs Product Introduction
10.2.5 Johnson & Johnson Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Dermatological Drugs
10.3.4 Dermatological Drugs Product Introduction
10.3.5 Pfizer Recent Development
10.4 Novartis
10.4.1 Novartis Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Dermatological Drugs
10.4.4 Dermatological Drugs Product Introduction
10.4.5 Novartis Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Dermatological Drugs
10.5.4 Dermatological Drugs Product Introduction
10.5.5 GlaxoSmithKline Recent Development
10.6 AstraZeneca
10.6.1 AstraZeneca Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Dermatological Drugs
10.6.4 Dermatological Drugs Product Introduction
10.6.5 AstraZeneca Recent Development
10.7 Galderma
10.7.1 Galderma Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Dermatological Drugs
10.7.4 Dermatological Drugs Product Introduction
10.7.5 Galderma Recent Development
10.8 Amgen
10.8.1 Amgen Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Dermatological Drugs
10.8.4 Dermatological Drugs Product Introduction
10.8.5 Amgen Recent Development
10.9 AbbVie
10.9.1 AbbVie Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Dermatological Drugs
10.9.4 Dermatological Drugs Product Introduction
10.9.5 AbbVie Recent Development
10.10 Merck
10.10.1 Merck Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Dermatological Drugs
10.10.4 Dermatological Drugs Product Introduction
10.10.5 Merck Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Dermatological Drugs Sales Channels
11.2.2 Dermatological Drugs Distributors
11.3 Dermatological Drugs Customers
12 Market Forecast
12.1 Global Dermatological Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Dermatological Drugs Sales Forecast by Type
12.3 Global Dermatological Drugs Sales Forecast by Application
12.4 Dermatological Drugs Forecast by Regions
12.4.1 Global Dermatological Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Dermatological Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Dermatological Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Prescription-Based Drugs
1.3.3 Over-the-Counter Drugs
1.4 Market Segment by Application
1.4.1 Global Dermatological Drugs Market Share by Application (2019-2025)
1.4.2 Acne
1.4.3 Skin Infections
1.4.4 Psoriasis
1.4.5 Dermatitis Drugs
1.4.6 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dermatological Drugs Market Size
2.1.1 Global Dermatological Drugs Revenue 2014-2025
2.1.2 Global Dermatological Drugs Sales 2014-2025
2.2 Dermatological Drugs Growth Rate by Regions
2.2.1 Global Dermatological Drugs Sales by Regions 2014-2019
2.2.2 Global Dermatological Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Dermatological Drugs Sales by Manufacturers
3.1.1 Dermatological Drugs Sales by Manufacturers 2014-2019
3.1.2 Dermatological Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Dermatological Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Dermatological Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Dermatological Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Dermatological Drugs Price by Manufacturers
3.4 Key Manufacturers Dermatological Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Dermatological Drugs Market
3.6 Key Manufacturers Dermatological Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Prescription-Based Drugs Sales and Revenue (2014-2019)
4.1.2 Over-the-Counter Drugs Sales and Revenue (2014-2019)
4.2 Global Dermatological Drugs Sales Market Share by Type
4.3 Global Dermatological Drugs Revenue Market Share by Type
4.4 Dermatological Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Dermatological Drugs Sales by Application
6 United States
6.1 United States Dermatological Drugs Breakdown Data by Company
6.2 United States Dermatological Drugs Breakdown Data by Type
6.3 United States Dermatological Drugs Breakdown Data by Application
7 European Union
7.1 European Union Dermatological Drugs Breakdown Data by Company
7.2 European Union Dermatological Drugs Breakdown Data by Type
7.3 European Union Dermatological Drugs Breakdown Data by Application
8 China
8.1 China Dermatological Drugs Breakdown Data by Company
8.2 China Dermatological Drugs Breakdown Data by Type
8.3 China Dermatological Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Dermatological Drugs Breakdown Data by Company
9.2 Rest of World Dermatological Drugs Breakdown Data by Type
9.3 Rest of World Dermatological Drugs Breakdown Data by Application
9.4 Rest of World Dermatological Drugs Breakdown Data by Countries
9.4.1 Rest of World Dermatological Drugs Sales by Countries
9.4.2 Rest of World Dermatological Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Dermatological Drugs
10.1.4 Dermatological Drugs Product Introduction
10.1.5 Bayer Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Dermatological Drugs
10.2.4 Dermatological Drugs Product Introduction
10.2.5 Johnson & Johnson Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Dermatological Drugs
10.3.4 Dermatological Drugs Product Introduction
10.3.5 Pfizer Recent Development
10.4 Novartis
10.4.1 Novartis Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Dermatological Drugs
10.4.4 Dermatological Drugs Product Introduction
10.4.5 Novartis Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Dermatological Drugs
10.5.4 Dermatological Drugs Product Introduction
10.5.5 GlaxoSmithKline Recent Development
10.6 AstraZeneca
10.6.1 AstraZeneca Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Dermatological Drugs
10.6.4 Dermatological Drugs Product Introduction
10.6.5 AstraZeneca Recent Development
10.7 Galderma
10.7.1 Galderma Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Dermatological Drugs
10.7.4 Dermatological Drugs Product Introduction
10.7.5 Galderma Recent Development
10.8 Amgen
10.8.1 Amgen Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Dermatological Drugs
10.8.4 Dermatological Drugs Product Introduction
10.8.5 Amgen Recent Development
10.9 AbbVie
10.9.1 AbbVie Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Dermatological Drugs
10.9.4 Dermatological Drugs Product Introduction
10.9.5 AbbVie Recent Development
10.10 Merck
10.10.1 Merck Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Dermatological Drugs
10.10.4 Dermatological Drugs Product Introduction
10.10.5 Merck Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Dermatological Drugs Sales Channels
11.2.2 Dermatological Drugs Distributors
11.3 Dermatological Drugs Customers
12 Market Forecast
12.1 Global Dermatological Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Dermatological Drugs Sales Forecast by Type
12.3 Global Dermatological Drugs Sales Forecast by Application
12.4 Dermatological Drugs Forecast by Regions
12.4.1 Global Dermatological Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Dermatological Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
